Education
About Us
Working with TipRanks
Follow Us
Stoke Therapeutics (STOK)
:STOK
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 36.55M | $ 8.78M | $ 12.40M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 36.55M | $ 8.78M | $ 12.40M | $ -2.23M | $ -1.93M |
| Operating Income | $ -101.37M | $ -114.77M | $ -104.36M | $ -86.06M | $ -53.04M |
| EBITDA | $ -99.19M | $ -112.30M | $ -102.81M | $ -83.58M | $ -50.32M |
| Net Income | $ -88.98M | $ -104.70M | $ -101.07M | $ -85.81M | $ -52.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 216.90M | $ 201.39M | $ 229.59M | $ 219.81M | $ 287.31M |
| Total Assets | $ 271.56M | $ 228.34M | $ 256.07M | $ 238.87M | $ 297.93M |
| Total Debt | $ 2.32M | $ 2.06M | $ 2.36M | $ 1.51M | $ 1.15M |
| Net Debt | $ -125.66M | $ -189.38M | $ -111.20M | $ -143.39M | $ -287.23M |
| Total Liabilities | $ 42.53M | $ 68.78M | $ 71.22M | $ 21.09M | $ 11.85M |
| Stockholders' Equity | $ 229.02M | $ 159.56M | $ 184.85M | $ 217.78M | $ 286.08M |
| Cash Flow | |||||
| Free Cash Flow | $ -87.05M | $ -82.68M | $ -35.83M | $ -68.11M | $ -43.27M |
| Operating Cash Flow | $ -86.85M | $ -81.07M | $ -31.87M | $ -66.91M | $ -42.22M |
| Investing Cash Flow | $ -107.47M | $ 105.95M | $ -45.88M | $ -76.43M | $ -1.05M |
| Financing Cash Flow | $ 131.09M | $ 53.01M | $ 46.41M | $ 1.28M | $ 108.11M |